Sudden death in noncoronary heart disease is associated with delayed paced ventricular activation

Circulation

Volumn 107, Issue 20, 2003, Pages 2595-2600

  Saumarez, Richard C ^a   Chojnowska, Lidia ^b   Derksen, Richard ^c   Pytkowski, Mariusz ^b   Sterlinski, Maciej ^b   Huang, Christopher L H ^a   Sadoul, Nicolas ^d   Hauer, Richard N W ^c   Ruzyłło, Witold ^b   Grace, Andrew A ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b INSTITUTE OF CARDIOLOGY   (Poland)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

Cardiomyopathy; Death, sudden; Electrophysiology; Long QT syndrome

Indexed keywords

ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ELECTROGRAPHY; HEART DILATATION; HEART MUSCLE REFRACTORY PERIOD; HEART VENTRICLE FIBRILLATION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; LONG QT SYNDROME; MAJOR CLINICAL STUDY; PACED ELECTROGRAM FRACTIONATION ANALYSIS; PREDICTION; PRIORITY JOURNAL; REENTRY ARRHYTHMIA; SUDDEN DEATH;

EID: 0038689295     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.cir.0000068342.96569.a1     Document Type: Article

References (34)

1. Huikuri HV, Castellanos A, Myerburg RJ. Sudden death due to cardiac arrhythmias. N Engl J Med. 2001;345:1473-1482.
2. Priori SG, Aliot E, Blomstrom-Lundqvist C, et al. Task Force on Sudden Cardiac Death of the European Society of Cardiology. Eur Heart J. 2001;22:1374-1450.
3. Zipes DP, Wellens HJ. Sudden cardiac death. Circulation. 1998;98:2334-2351.
4. Maron BJ, Shen WK, Link MS, et al. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med. 2000;342:365-373.
5. Bigger JT. Expanding indications for implantable cardiac defibrillators. N Engl J Med. 2002;346:931-933.
6. Kadish A. Primary prevention of sudden death using ICD therapy: incremental steps. J Am Coll Cardiol. 2002;39:788-789.
7. Jalife J. Ventricular fibrillation: mechanisms of initiation and maintenance. Annu Rev Physiol. 2000;62:25-50.
8. Janse MJ, Downar E, Reentry. In: Spooner PM, Rosen MR, eds. Foundations of Cardiac Arrhythmias: Basic and Clinical Approaches. New York: Marcel Dekker; 2001:449-477.
9. Kawara T, Derksen R, de Groot JR, et al. Activation delay after premature stimulation in chronically diseased human myocardium relates to the architecture of interstitial fibrosis. Circulation. 2001;104:3069-3075.
10. Soejima K, Stevenson WG, Maisel WH, et al. The N+1 difference: a new measure for entrainment mapping. J Am Coll Cardiol. 2001;37:1386-1394.
11. Spach MS, Dolber PC, Heidlage JF. Influence of the passive anisotropic properties on directional differences in propagation following modification of the sodium conductance in human atrial muscle: a model of reentry based on anisotropic discontinuous propagation. Circ Res. 1988;62:811-832.
12. Spach MS. Anisotropic structural complexities in the genesis of reentrant arrhythmias. Circulation. 1991;84:1447-1450.
13. Saumarez RC, Camm AJ, Panagos A, et al. Ventricular fibrillation in hypertrophic cardiomyopathy is associated with increased fractionation of paced right ventricular electrograms. Circulation. 1992;86:467-474.
14. Saumarez RC, Slade AK, Grace AA, et al. The significance of paced electrogram fractionation in hypertrophic cardiomyopathy: a prospective study. Circulation. 1995;91:2762-2768.
15. Saumarez RC, Heald S, Gill J, et al. Primary ventricular fibrillation is associated with increased paced right ventricular electrogram fractionation. Circulation. 1995;92:2565-2571.
16. Varnava AM, Elliott PM, Sharma S, et al. Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease. Heart. 2000;84:476-482.
17. Saumarez RC, Grace AA. Paced ventricular electrogram fractionation and sudden death in hypertrophic cardiomyopathy and other non-coronary heart diseases. Cardiovasc Res. 2000;47:11-23.
18. Grace AA, Brady PA, Shapiro LM. Risk management in hypertrophic cardiomyopathy. Lancet. 2001;357:407-408.
19. Cranefield PF. The Conduction of the Cardiac Impulse: The Slow Response and Cardiac Arrhythmias. Mount Kisco, New York: Futura; 1975.
20. Papadatos GA, Wallerstein PM, Head CE, et al. Slowed conduction and ventricular tachycardia after targeted disruption of the cardiac sodium channel gene Scn5a. Proc Natl Acad Sci U S A. 2002;99:6210-6215.
21. Noble D. Unraveling the genetics and mechanisms of cardiac arrhythmia. Proc Natl Acad Sci U S A. 2002;99:5755-5756.
22. Tomaselli GF, Marban E. Electrophysiological remodeling in hypertrophy and heart failure. Cardiovasc Res. 1999;42:270-283.
23. de Bakker JM, van Capelle FJ, Janse MJ, et al. Fractionated electrograms in dilated cardiomyopathy: origin and relation to abnormal conduction. J Am Coll Cardiol. 1996;27:1071-1078.
24. Marban E. Cardiac channelopathies. Nature. 2002;415:213-218.
25. Roden DM. The problem, challenge and opportunity of genetic heterogeneity in monogenic diseases predisposing to sudden death. J Am Coll Cardiol. 2002;40:357-359.
26. Schram G, Pourrier M, Melnyk P, et al. Differential distribution of cardiac ion channel expression as a basis for regional specialization in electrical function. Circ Res. 2002;90:939-950.
27. Spirito P, Seidman CE, McKenna WJ, et al. The management of hypertrophic cardiomyopathy. N Engl J Med. 1997;336:775-785.
28. Fananapazir L, Chang AC, Epstein SE, et al. Prognostic determinants in hypertrophic cardiomyopathy: prospective evaluation of a therapeutic strategy based on clinical, Holter, hemodynamic, and electrophysiological findings. Circulation. 1992;86:730-740.
29. Bhandari AK, Shapiro WA, Morady F, et al. Electrophysiologic testing in patients with the long QT syndrome. Circulation. 1985;71:63-71.
30. Turitto G, Ahuja RK, Caref EB, et al. Risk stratification for arrhythmic events in patients with nonischemic dilated cardiomyopathy and nonsustained ventricular tachycardia: role of programmed ventricular stimulation and the signal-averaged electrocardiogram. J Am Coll Cardiol. 1994;24:1523-1528.
31. Grimm W, Hoffmann J, Menz V, et al. Programmed ventricular stimulation for arrhythmia risk prediction in patients with idiopathic dilated cardiomyopathy and nonsustained ventricular tachycardia. J Am Coll Cardiol. 1998;32:739-745.
32. Rogers JM, Huang J, Smith WM, et al. Incidence, evolution, and spatial distribution of functional reentry during ventricular fibrillation in pigs. Circ Res. 1999;84:945-954.
33. Pogwizd SM, McKenzie JP, Cain ME. Mechanisms underlying spontaneous and induced ventricular arrhythmias in patients with idiopathic dilated cardiomyopathy. Circulation. 1998;98:2404-2414.
34. Kanda M, Shimizu W, Matsuo K, et al. Electrophysiologic characteristics and implications of induced ventricular fibrillation in symptomatic patients with Brugada syndrome. J Am Coll Cardiol. 2002;39:1799-1805.